GB0012199D0 - New polypeptide - Google Patents

New polypeptide

Info

Publication number
GB0012199D0
GB0012199D0 GBGB0012199.6A GB0012199A GB0012199D0 GB 0012199 D0 GB0012199 D0 GB 0012199D0 GB 0012199 A GB0012199 A GB 0012199A GB 0012199 D0 GB0012199 D0 GB 0012199D0
Authority
GB
United Kingdom
Prior art keywords
new polypeptide
polypeptide
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0012199.6A
Other versions
GB2365432A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0012199A priority Critical patent/GB2365432A/en
Publication of GB0012199D0 publication Critical patent/GB0012199D0/en
Publication of GB2365432A publication Critical patent/GB2365432A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0012199A 2000-05-19 2000-05-19 Neurotransmitter transporter polypeptide Withdrawn GB2365432A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0012199A GB2365432A (en) 2000-05-19 2000-05-19 Neurotransmitter transporter polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0012199A GB2365432A (en) 2000-05-19 2000-05-19 Neurotransmitter transporter polypeptide

Publications (2)

Publication Number Publication Date
GB0012199D0 true GB0012199D0 (en) 2000-07-12
GB2365432A GB2365432A (en) 2002-02-20

Family

ID=9891980

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0012199A Withdrawn GB2365432A (en) 2000-05-19 2000-05-19 Neurotransmitter transporter polypeptide

Country Status (1)

Country Link
GB (1) GB2365432A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059947A1 (en) * 2002-01-04 2003-07-24 Bayer Healthcare Ag Regulation of human neurotransmitter transporter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031539A1 (en) * 1994-05-16 1995-11-23 Human Genome Sciences, Inc. Neurotransmitter transporter

Also Published As

Publication number Publication date
GB2365432A (en) 2002-02-20

Similar Documents

Publication Publication Date Title
AU8441801A (en) Novel polypeptide
GB0015761D0 (en) Polypeptide
GB0127017D0 (en) New polypeptide
GB0025572D0 (en) New polypeptide
GB0120704D0 (en) Polypeptide
GB0127028D0 (en) New polypeptide
GB0025677D0 (en) New protein
EP1354947A4 (en) Novel polypeptide
GB0012199D0 (en) New polypeptide
GB0018307D0 (en) Polypeptides
GB0013239D0 (en) Polypeptide
GB0109286D0 (en) New polypeptide
GB0030501D0 (en) New polypeptide
GB0024445D0 (en) New polypeptide
GB0019859D0 (en) New polypeptide
GB0021524D0 (en) Polypeptide
GB0023444D0 (en) Polypeptide
GB0027166D0 (en) Polypeptide
GB0030293D0 (en) Polypeptide
GB0019861D0 (en) Polypeptide
GB0010170D0 (en) Polypeptide
GB0009070D0 (en) Novel polypeptide
GB0009973D0 (en) Novel polypeptide
GB0018238D0 (en) Novel polypeptide
GB0014827D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)